Cargando…

NeurEx: digitalized neurological examination offers a novel high‐resolution disability scale

OBJECTIVE: To develop a sensitive neurological disability scale for broad utilization in clinical practice. METHODS: We employed advances of mobile computing to develop an iPad‐based App for convenient documentation of the neurological examination into a secure, cloud‐linked database. We included fe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kosa, Peter, Barbour, Christopher, Wichman, Alison, Sandford, Mary, Greenwood, Mark, Bielekova, Bibiana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186944/ https://www.ncbi.nlm.nih.gov/pubmed/30349859 http://dx.doi.org/10.1002/acn3.640

Ejemplares similares

Identifying and Quantifying Neurological Disability via Smartphone
por: Boukhvalova, Alexandra K., et al.
Publicado: (2018)

Molecular models of multiple sclerosis severity identify heterogeneity of pathogenic mechanisms
por: Kosa, Peter, et al.
Publicado: (2022)

Idebenone does not inhibit disability progression in primary progressive MS
por: Kosa, Peter, et al.
Publicado: (2020)

New Multiple Sclerosis Disease Severity Scale Predicts Future Accumulation of Disability
por: Weideman, Ann Marie, et al.
Publicado: (2017)

Confounder-adjusted MRI-based predictors of multiple sclerosis disability
por: Kim, Yujin, et al.
Publicado: (2022)

Smartphone Level Test Measures Disability in Several Neurological Domains for Patients With Multiple Sclerosis
por: Boukhvalova, Alexandra K., et al.
Publicado: (2019)

Extensive Healthy Donor Age/Gender Adjustments and Propensity Score Matching Reveal Physiology of Multiple Sclerosis Through Immunophenotyping
por: Hannikainen, Paavali A., et al.
Publicado: (2020)

Third workshop on Bayesian Deep Learning (NeurIPS 2018)
Publicado: (2018)

Intrathecal, Not Systemic Inflammation Is Correlated With Multiple Sclerosis Severity, Especially in Progressive Multiple Sclerosis
por: Milstein, Joshua L., et al.
Publicado: (2019)

Enhancing the clinical value of serum neurofilament light chain measurement
por: Kosa, Peter, et al.
Publicado: (2022)

Machine learning-optimized Combinatorial MRI scale (COMRISv2) correlates highly with cognitive and physical disability scales in Multiple Sclerosis patients
por: Kelly, Erin, et al.
Publicado: (2022)

36th Conference on Neural Information Processing Systems (NeurIPS 2022)
Publicado: (2022)

Smartphone-based symbol-digit modalities test reliably captures brain damage in multiple sclerosis
por: Pham, Linh, et al.
Publicado: (2021)

32nd Annual Conference on Neural Information Processing Systems (NeurIPS 2018)
por: Escalera, Sergio, et al.
Publicado: (2020)

RD-Connect, NeurOmics and EURenOmics: collaborative European initiative for rare diseases
por: Lochmüller, Hanns, et al.
Publicado: (2018)

Co‐producing research with youth: The NeurOx young people's advisory group model
por: Pavarini, Gabriela, et al.
Publicado: (2019)

1820. Efficacy of Pulse-Taper Corticosteroid Adjunctive Therapy for Refractory Non-HIV Cryptococcal Meningoencephalitis
por: Anjum, Seher, et al.
Publicado: (2019)

Assessment of Smartphone-Based Spiral Tracing in Multiple Sclerosis Reveals Intra-Individual Reproducibility as a Major Determinant of the Clinical Utility of the Digital Test
por: Messan, Komi S., et al.
Publicado: (2022)

“Neur”al brain wave: Coordinating epithelial-to-neural stem cell transition in the fly optic lobe
por: Ambrosini, Arnaud, et al.
Publicado: (2020)

Finger and foot tapping as alternative outcomes of upper and lower extremity function in multiple sclerosis
por: Tanigawa, Makoto, et al.
Publicado: (2017)

Development of a Sensitive Outcome for Economical Drug Screening for Progressive Multiple Sclerosis Treatment
por: Kosa, Peter, et al.
Publicado: (2016)

Pioglitazone regulates myelin phagocytosis and multiple sclerosis monocytes
por: Natrajan, Muktha S., et al.
Publicado: (2015)

Intrathecal B Cells in MS Have Significantly Greater Lymphangiogenic Potential Compared to B Cells Derived From Non-MS Subjects
por: Stein, Jason, et al.
Publicado: (2018)

Pharmacodynamic effects of daclizumab in the intrathecal compartment
por: Komori, Mika, et al.
Publicado: (2017)

Meta-analysis of the Age-Dependent Efficacy of Multiple Sclerosis Treatments
por: Weideman, Ann Marie, et al.
Publicado: (2017)

Current Status and Future Opportunities in Modeling Clinical Characteristics of Multiple Sclerosis
por: Liu, Joshua, et al.
Publicado: (2022)

Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis
por: Komori, Mika, et al.
Publicado: (2016)

How Implementation of Systems Biology into Clinical Trials Accelerates Understanding of Diseases
por: Bielekova, Bibiana, et al.
Publicado: (2014)

Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trials
por: Zhang, Yinan, et al.
Publicado: (2020)

Neurological Examination
Publicado: (1929)

Biomarkers in Multiple Sclerosis
por: Martin, Roland, et al.
Publicado: (2006)

Multicentre, double-blind, crossover trial to identify the Optimal Pathway for TreatIng neurOpathic paiN in Diabetes Mellitus (OPTION-DM): study protocol for a randomised controlled trial
por: Selvarajah, Dinesh, et al.
Publicado: (2018)

Examining the Relationship Between Community Integration and Mental Health Characteristics of Individuals With Childhood Acquired Neurological Disability
por: Nguyen, Christine, et al.
Publicado: (2021)

Prognostic Value of Serum/Plasma Neurofilament Light Chain for COVID-19 Associated Mortality
por: Masvekar, Ruturaj R., et al.
Publicado: (2022)

Prognostic value of serum/plasma neurofilament light chain for COVID‐19‐associated mortality
por: Masvekar, Ruturaj R., et al.
Publicado: (2022)

The Neurological Ecology of Fear: Insights Neuroscientists and Ecologists Have to Offer one Another
por: Clinchy, Michael, et al.
Publicado: (2011)

Cerebrospinal Fluid IL-12p40, CXCL13 and IL-8 as a Combinatorial Biomarker of Active Intrathecal Inflammation
por: Bielekova, Bibiana, et al.
Publicado: (2012)

Cerebrospinal Fluid Biomarkers of Myeloid and Glial Cell Activation Are Correlated With Multiple Sclerosis Lesional Inflammatory Activity
por: Masvekar, Ruturaj, et al.
Publicado: (2021)

The rights of persons with disability bill, 2014: Implications for neurological disability
por: Math, Suresh Bada, et al.
Publicado: (2016)

Incomplete Susac syndrome exacerbated after natalizumab
por: Zhovtis Ryerson, Lana, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jke8elmviio78oq2aaaben4a2j